Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab After Radiotherapy Alone in Elderly Esophageal Squamous Cell Carcinoma: A Prospective Phase II Clinical Trial

NCT05791136 is registered in ClinicalTrials.gov with The Central Hospital of Lishui City as lead sponsor.

NCT NCT05791136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05791136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab After Radiotherapy Alone in Elderly Esophageal Squamous Cell Carcinoma: A Prospective Phase II Clinical Trial
Lead sponsor
The Central Hospital of Lishui City
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2023
Completion date
June 30, 2026
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal squamous cell carcinoma by ajcc v8 stage